Siequi is a patient-facing symptom companion for psoriasis and eczema, built to bring longitudinal, structured data into a consultation that's usually built on recall alone. We're currently in early pilot conversations with dermatologists and clinics.
Patients using Siequi can choose to share a structured summary ahead of an appointment — daily symptom trends, validated questionnaire results (the same instruments already in clinical use), and any patterns the app has flagged for discussion. Nothing is sent without the patient's explicit, revocable consent.
This is meant to sit alongside your existing workflow, not replace your judgment or your record-keeping.
Siequi is pre-launch. The product is built; the clinical evidence underlying its content is currently under structured review by dermatology advisors before it informs any patient- or clinician-facing claims. We're not asking dermatologists to endorse finished content — we're looking for a small number of early partners to help shape it.
There's no fixed pilot package to opt into yet. Early conversations are exploratory — understanding whether Siequi's approach fits your patients and your workflow, and where your input would be most useful, whether that's clinical review, structured feedback, or a small-scale trial.